Panelists discuss how heart failure creates a massive economic burden of approximately $30 billion annually (expected to ...

Advancements in breast cancer care and treatments with reproductive and urinary oncologist Lakshminarayanan Nandagopal, MD.

Michaela Nuttal, MS, explores the complex culture of smoking among nurses, highlighting challenges and motivations for ...

There are clear benefits to starting biologic therapy earlier for severe asthma, as well as initiation patterns by ethnicity, ...

Raludotatug deruxtecan (R-DXd) received FDA breakthrough therapy designation for CDH6-expressing platinum-resistant ovarian, primary peritoneal, or fallopian tube cancers. Phase 1 study demonstrated a ...

Ana Baramidze, MD, head of the Department of Clinical Researches at the Todua Clinic in Tbilisi, Georgia, explained how ...

Panelists discuss how heart failure affects 1 in 4 people over their lifetime with 7 million current cases in the US, while Optum Health has implemented an innovative screening program using symptom ...

On Monday, the FDA approved guselkumab (Tremfya; Johnson & Johnson) for the treatment of children 6 and older who also weigh at least 40 kg with plaque psoriasis (PsO) and active psoriatic arthritis ...

Digital health technologies are reshaping respiratory medicine, from home-based monitoring in chronic lung disease to ...

Experts presented new insights on the impact of indoor air pollution from biomass combustion and household cleaning products, ...

Expanding community-based cancer services brings advanced treatments closer to home and addresses social determinants of ...

A lively pro-con session on e-cigarettes sparked discussion on their role in smoking cessation and public health during the ...